Circulating miRNAs as Tumor Biomarkers
This special issue belongs to the section "Cancer Biomarkers".
Special Issue Information
Dear Colleagues,
miRNAs are short non-coding RNA molecules that regulate mRNA expression post-transcriptionally. These molecules are being excreted extracellularly and detected in many types of body fluids, such as blood, urine, etc. The presence of circulating miRNAs in peripheral blood in a highly stable manner has positioned them as promising noninvasive new biomarkers for a wide range of diagnostic applications. Their role has been studied extensively mainly on diagnosis, prognosis, and resistance to therapy for several types of human cancers.
This Special Issue will highlight the clinical importance of circulating miRNAs as biomarkers, the effects of various preanalytical and analytical parameters on their measurements, as well as technological advances that will further improve our knowledge in the field of early diagnosis and detection of minimal residual disease.
Dr. Athina N. Markou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- circulating miRNAs
- preanalytical factors
- early diagnosis
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

